| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 8.27e-12 | 11 | 105 | 6 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 3.23e-10 | 18 | 105 | 6 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.70e-10 | 19 | 105 | 6 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.28e-09 | 22 | 105 | 6 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 7.53e-09 | 50 | 105 | 7 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride channel activity | 3.47e-07 | 86 | 105 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.34e-07 | 57 | 105 | 6 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.28e-07 | 60 | 105 | 6 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.18e-06 | 65 | 105 | 6 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.18e-06 | 65 | 105 | 6 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.19e-06 | 103 | 105 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.75e-06 | 75 | 105 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 3.21e-06 | 77 | 105 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.36e-06 | 125 | 105 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 8.25e-06 | 193 | 105 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.58e-06 | 197 | 105 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.46e-05 | 100 | 105 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.51e-05 | 151 | 105 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 2.74e-05 | 2 | 105 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.36e-05 | 171 | 105 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 1.63e-04 | 4 | 105 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 1.63e-04 | 4 | 105 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.64e-04 | 24 | 105 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.85e-04 | 334 | 105 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 7.51e-04 | 8 | 105 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 8.01e-04 | 79 | 105 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.20e-03 | 10 | 105 | 2 | GO:0015924 | |
| GeneOntologyMolecularFunction | channel activity | 1.80e-03 | 525 | 105 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.83e-03 | 526 | 105 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | complement receptor activity | 2.39e-03 | 14 | 105 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 2.75e-03 | 15 | 105 | 2 | GO:0004559 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 2.75e-03 | 15 | 105 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.93e-03 | 459 | 105 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | mannosidase activity | 3.13e-03 | 16 | 105 | 2 | GO:0015923 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 4.89e-03 | 20 | 105 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 5.79e-03 | 136 | 105 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 5.79e-03 | 136 | 105 | 4 | GO:0004519 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 1.17e-10 | 30 | 103 | 7 | GO:1904862 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.93e-08 | 35 | 103 | 6 | GO:0007214 | |
| GeneOntologyBiologicalProcess | hindbrain tangential cell migration | 1.20e-06 | 5 | 103 | 3 | GO:0021934 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.49e-06 | 112 | 103 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.88e-06 | 74 | 103 | 6 | GO:0051932 | |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB2 GABRG2 GABRG3 RELN LHFPL4 DSCAM GABRA2 GABRA3 GABRA5 GABRA6 | 3.30e-06 | 308 | 103 | 10 | GO:0007416 |
| GeneOntologyBiologicalProcess | chloride transport | 3.63e-06 | 128 | 103 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 4.92e-06 | 134 | 103 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.18e-05 | 153 | 103 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 3.36e-05 | 180 | 103 | 7 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 3.36e-05 | 180 | 103 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.73e-05 | 183 | 103 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | somitogenesis | 3.93e-05 | 76 | 103 | 5 | GO:0001756 | |
| GeneOntologyBiologicalProcess | somite development | 1.09e-04 | 94 | 103 | 5 | GO:0061053 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB2 GABRG2 GABRG3 RELN LHFPL4 DSCAM EPB41L5 GABRA2 GABRA3 GABRA5 GABRA6 | 1.29e-04 | 569 | 103 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | respiratory system development | 1.47e-04 | 305 | 103 | 8 | GO:0060541 | |
| GeneOntologyBiologicalProcess | tube development | EPHB2 FNDC3B FLT1 MAN2A1 MUC19 EPB41L5 TERT TBX18 FOXB1 ADRA2B GPC3 DHCR7 LTBP3 C5AR1 CSMD1 PLXNA2 ADAMTSL2 FOXC2 | 1.86e-04 | 1402 | 103 | 18 | GO:0035295 |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 1.99e-04 | 23 | 103 | 3 | GO:0021535 | |
| GeneOntologyBiologicalProcess | de novo centriole assembly involved in multi-ciliated epithelial cell differentiation | 2.45e-04 | 5 | 103 | 2 | GO:0098535 | |
| GeneOntologyBiologicalProcess | de novo centriole assembly | 3.66e-04 | 6 | 103 | 2 | GO:0097742 | |
| GeneOntologyBiologicalProcess | segmentation | 3.82e-04 | 123 | 103 | 5 | GO:0035282 | |
| GeneOntologyBiologicalProcess | lung development | 4.05e-04 | 269 | 103 | 7 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 4.43e-04 | 273 | 103 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRG2 GABRG3 RELN WWP2 TBX18 PHOX2B GABRA2 GABRA3 GABRA5 GABRA6 | 4.87e-04 | 559 | 103 | 10 | GO:0042391 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 4.01e-10 | 19 | 107 | 6 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 7.96e-10 | 21 | 107 | 6 | GO:1902710 | |
| GeneOntologyCellularComponent | dendrite membrane | 4.12e-07 | 56 | 107 | 6 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.58e-07 | 57 | 107 | 6 | GO:0034707 | |
| GeneOntologyCellularComponent | neuron projection membrane | 3.99e-06 | 82 | 107 | 6 | GO:0032589 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.17e-05 | 164 | 107 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | procentriole | 7.76e-05 | 3 | 107 | 2 | GO:0120098 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.04e-04 | 210 | 107 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | procentriole replication complex | 3.84e-04 | 6 | 107 | 2 | GO:0120099 | |
| GeneOntologyCellularComponent | deuterosome | 3.84e-04 | 6 | 107 | 2 | GO:0098536 | |
| GeneOntologyCellularComponent | inhibitory synapse | 5.28e-04 | 31 | 107 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | receptor complex | GABRG2 GABRG3 FLT1 CR1 PLXNA2 GABRA2 TRAV16 GABRA3 GABRA5 GABRA6 | 7.99e-04 | 581 | 107 | 10 | GO:0043235 |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.14e-03 | 405 | 107 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.98e-03 | 656 | 107 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.02e-03 | 658 | 107 | 10 | GO:0030312 | |
| MousePheno | abnormal GABA-mediated receptor currents | 3.83e-06 | 18 | 86 | 4 | MP:0004008 | |
| Domain | GABAA/Glycine_rcpt | 2.55e-09 | 23 | 105 | 6 | IPR006028 | |
| Domain | GABAAa_rcpt | 1.40e-08 | 6 | 105 | 4 | IPR001390 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.86e-07 | 45 | 105 | 6 | IPR018000 | |
| Domain | Neur_chan_memb | 2.13e-07 | 46 | 105 | 6 | PF02932 | |
| Domain | Neur_chan_LBD | 2.43e-07 | 47 | 105 | 6 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.43e-07 | 47 | 105 | 6 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 2.43e-07 | 47 | 105 | 6 | IPR006029 | |
| Domain | - | 2.43e-07 | 47 | 105 | 6 | 2.70.170.10 | |
| Domain | Neur_channel | 2.43e-07 | 47 | 105 | 6 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.43e-07 | 47 | 105 | 6 | IPR006202 | |
| Domain | GABBAg_rcpt | 9.36e-05 | 3 | 105 | 2 | IPR005437 | |
| Domain | HSNSD | 1.86e-04 | 4 | 105 | 2 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 1.86e-04 | 4 | 105 | 2 | IPR021930 | |
| Domain | - | 3.10e-04 | 5 | 105 | 2 | 1.20.1270.50 | |
| Domain | - | 3.10e-04 | 5 | 105 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_C | 3.10e-04 | 5 | 105 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 3.10e-04 | 5 | 105 | 2 | SM00872 | |
| Domain | Alpha-mann_mid | 3.10e-04 | 5 | 105 | 2 | PF09261 | |
| Domain | Glyco_hydro_38_N | 3.10e-04 | 5 | 105 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 3.10e-04 | 5 | 105 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 3.10e-04 | 5 | 105 | 2 | IPR015341 | |
| Domain | Glyco_hydro_57/38_cen | 3.10e-04 | 5 | 105 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38C | 3.10e-04 | 5 | 105 | 2 | PF07748 | |
| Domain | Glyco_hydro_38 | 3.10e-04 | 5 | 105 | 2 | PF01074 | |
| Domain | RNase_Zc3h12a | 6.45e-04 | 7 | 105 | 2 | PF11977 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 6.45e-04 | 7 | 105 | 2 | IPR011330 | |
| Domain | RNase_Zc3h12_NYN | 6.45e-04 | 7 | 105 | 2 | IPR021869 | |
| Domain | PROTEIN_KINASE_TYR | 2.19e-03 | 97 | 105 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.19e-03 | 97 | 105 | 4 | IPR008266 | |
| Domain | - | 2.73e-03 | 14 | 105 | 2 | 2.60.40.1180 | |
| Domain | Sushi | 3.12e-03 | 52 | 105 | 3 | PF00084 | |
| Domain | - | 3.13e-03 | 15 | 105 | 2 | 1.10.150.60 | |
| Domain | Glyco_hydro_b | 3.13e-03 | 15 | 105 | 2 | IPR013780 | |
| Domain | BRIGHT | 3.13e-03 | 15 | 105 | 2 | SM00501 | |
| Domain | ARID_dom | 3.13e-03 | 15 | 105 | 2 | IPR001606 | |
| Domain | ARID | 3.13e-03 | 15 | 105 | 2 | PS51011 | |
| Domain | ARID | 3.13e-03 | 15 | 105 | 2 | PF01388 | |
| Domain | CCP | 3.48e-03 | 54 | 105 | 3 | SM00032 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | SM00216 | |
| Domain | VWF_type-D | 3.57e-03 | 16 | 105 | 2 | IPR001846 | |
| Domain | VWFD | 3.57e-03 | 16 | 105 | 2 | PS51233 | |
| Domain | VWD | 3.57e-03 | 16 | 105 | 2 | PF00094 | |
| Domain | SUSHI | 3.86e-03 | 56 | 105 | 3 | PS50923 | |
| Domain | Gal_mutarotase_SF_dom | 4.03e-03 | 17 | 105 | 2 | IPR011013 | |
| Domain | TF_T-box | 4.03e-03 | 17 | 105 | 2 | IPR001699 | |
| Domain | TBOX | 4.03e-03 | 17 | 105 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 4.03e-03 | 17 | 105 | 2 | IPR018186 | |
| Domain | - | 4.03e-03 | 17 | 105 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 4.03e-03 | 17 | 105 | 2 | PS50252 | |
| Domain | T-box | 4.03e-03 | 17 | 105 | 2 | PF00907 | |
| Domain | TBOX_1 | 4.03e-03 | 17 | 105 | 2 | PS01283 | |
| Domain | TBOX_2 | 4.03e-03 | 17 | 105 | 2 | PS01264 | |
| Domain | Sushi_SCR_CCP_dom | 4.05e-03 | 57 | 105 | 3 | IPR000436 | |
| Domain | Znf_CCCH | 4.26e-03 | 58 | 105 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 4.26e-03 | 58 | 105 | 3 | PS50103 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 1.33e-08 | 31 | 76 | 6 | M39369 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 4.84e-08 | 38 | 76 | 6 | M39854 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 9.63e-08 | 9 | 76 | 4 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.60e-07 | 10 | 76 | 4 | M477 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.98e-07 | 60 | 76 | 6 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.98e-07 | 60 | 76 | 6 | MM15708 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 3.45e-06 | 119 | 76 | 7 | M48309 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.76e-05 | 10 | 76 | 3 | MM1401 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.05e-04 | 272 | 76 | 8 | M13380 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.24e-04 | 144 | 76 | 6 | MM14501 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN | 2.84e-04 | 5 | 76 | 2 | M47875 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.33e-04 | 335 | 76 | 8 | MM14503 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 4.97e-04 | 29 | 76 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 6.07e-04 | 31 | 76 | 3 | M685 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.25e-04 | 205 | 76 | 6 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 9.58e-04 | 211 | 76 | 6 | MM14502 | |
| Pubmed | 1.33e-11 | 18 | 107 | 6 | 19078961 | ||
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 8.47e-11 | 4 | 107 | 4 | 19842164 | |
| Pubmed | 1.26e-09 | 6 | 107 | 4 | 9682826 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.26e-09 | 6 | 107 | 4 | 15033447 | |
| Pubmed | 1.26e-09 | 6 | 107 | 4 | 20457185 | ||
| Pubmed | 2.94e-09 | 7 | 107 | 4 | 7560270 | ||
| Pubmed | 5.87e-09 | 8 | 107 | 4 | 8175718 | ||
| Pubmed | 1.75e-08 | 10 | 107 | 4 | 36733270 | ||
| Pubmed | 1.75e-08 | 10 | 107 | 4 | 20583128 | ||
| Pubmed | 2.75e-08 | 11 | 107 | 4 | 39137998 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 2.75e-08 | 11 | 107 | 4 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 2.75e-08 | 11 | 107 | 4 | 38894703 | |
| Pubmed | 5.93e-08 | 13 | 107 | 4 | 22569571 | ||
| Pubmed | 5.93e-08 | 13 | 107 | 4 | 22640814 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 26518133 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 25865415 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 25080596 | ||
| Pubmed | 1.98e-07 | 81 | 107 | 6 | 22723691 | ||
| Pubmed | 2.51e-07 | 18 | 107 | 4 | 18985723 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 28978485 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 2.82e-07 | 5 | 107 | 3 | 30104684 | |
| Pubmed | 4.87e-07 | 21 | 107 | 4 | 25708312 | ||
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 21751815 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 16080114 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 9.82e-07 | 7 | 107 | 3 | 20843900 | |
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 17021187 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 35228700 | ||
| Pubmed | 9.82e-07 | 7 | 107 | 3 | 16101898 | ||
| Pubmed | GABA influences the development of the ventromedial nucleus of the hypothalamus. | 1.57e-06 | 8 | 107 | 3 | 11745664 | |
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 11528422 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 3.22e-06 | 130 | 107 | 6 | 19874574 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 3.34e-06 | 10 | 107 | 3 | 21789198 | |
| Pubmed | 7.92e-06 | 13 | 107 | 3 | 16870734 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11378843 | ||
| Pubmed | Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo. | 9.38e-06 | 2 | 107 | 2 | 10536013 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22763624 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35403940 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24641623 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23147414 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22666188 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8391122 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8524845 | ||
| Pubmed | Centrosomal organization of Cep152 provides flexibility in Plk4 and procentriole positioning. | 9.38e-06 | 2 | 107 | 2 | 37707473 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27833556 | ||
| Pubmed | Diazepam Accelerates GABAAR Synaptic Exchange and Alters Intracellular Trafficking. | 9.38e-06 | 2 | 107 | 2 | 31080408 | |
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 9.38e-06 | 2 | 107 | 2 | 18202657 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 36469977 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26446222 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16754854 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 14766194 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 9.38e-06 | 2 | 107 | 2 | 11021797 | |
| Pubmed | Cep152 interacts with Plk4 and is required for centriole duplication. | 9.38e-06 | 2 | 107 | 2 | 21059850 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24553732 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 9.38e-06 | 2 | 107 | 2 | 15341600 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17074040 | ||
| Pubmed | Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. | 9.38e-06 | 2 | 107 | 2 | 8649988 | |
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 9.38e-06 | 2 | 107 | 2 | 17113875 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23067879 | ||
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 9.38e-06 | 2 | 107 | 2 | 11778047 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 14570768 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 9.38e-06 | 2 | 107 | 2 | 26973458 | |
| Pubmed | 1.01e-05 | 14 | 107 | 3 | 22768092 | ||
| Pubmed | FNDC3B ICE2 REG3G SERINC2 ARID5A NDST3 LRIG3 EYS SPOCK3 HSD17B13 LYPD3 CSMD1 PLXNA2 | 1.08e-05 | 985 | 107 | 13 | 12975309 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 2.21e-05 | 182 | 107 | 6 | 20468064 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 11136737 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16674551 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27128218 | ||
| Pubmed | Asterless is a scaffold for the onset of centriole assembly. | 2.81e-05 | 3 | 107 | 2 | 20852615 | |
| Pubmed | Human Cep192 and Cep152 cooperate in Plk4 recruitment and centriole duplication. | 2.81e-05 | 3 | 107 | 2 | 23641073 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24843004 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29961870 | ||
| Pubmed | GABA Receptor SNPs and Elevated Plasma GABA Levels Affect the Severity of the Indian ASD Probands. | 2.81e-05 | 3 | 107 | 2 | 35562522 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17369310 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 20301776 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 15017002 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 14993607 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 17957331 | ||
| Pubmed | LINC01588 regulates WWP2-mediated cardiomyocyte injury by interacting with HNRNPL. | 2.81e-05 | 3 | 107 | 2 | 35258167 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 16835366 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 25891999 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 34530807 | ||
| Pubmed | Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome. | 2.81e-05 | 3 | 107 | 2 | 21059844 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 24277814 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 18085588 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29725984 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 1359369 | ||
| Pubmed | Chromosomal loci influencing chronic alcohol withdrawal severity. | 2.81e-05 | 3 | 107 | 2 | 12925894 | |
| Pubmed | Molecular architecture of a cylindrical self-assembly at human centrosomes. | 2.81e-05 | 3 | 107 | 2 | 30858376 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 31555286 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 15304513 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 19019179 | ||
| Pubmed | GARLH Family Proteins Stabilize GABAA Receptors at Synapses. | 2.81e-05 | 3 | 107 | 2 | 28279354 | |
| Pubmed | A cerebellar learning model of vestibulo-ocular reflex adaptation in wild-type and mutant mice. | 2.81e-05 | 3 | 107 | 2 | 24849355 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 29023704 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 1356407 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27889765 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 28816653 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 7851879 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 7601451 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 23611809 | ||
| Interaction | GPIHBP1 interactions | 6.19e-06 | 133 | 105 | 7 | int:GPIHBP1 | |
| Cytoband | 15q12 | 1.92e-04 | 9 | 107 | 2 | 15q12 | |
| Cytoband | 19q13.3-q13.4 | 4.13e-04 | 13 | 107 | 2 | 19q13.3-q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q12 | 8.04e-04 | 18 | 107 | 2 | chr15q12 | |
| Cytoband | 4p12 | 9.95e-04 | 20 | 107 | 2 | 4p12 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.27e-10 | 19 | 77 | 6 | 563 | |
| GeneFamily | Mannosidases alpha class 2 | 1.78e-04 | 5 | 77 | 2 | 1194 | |
| GeneFamily | Complement system|Sushi domain containing | 4.79e-04 | 36 | 77 | 3 | 492 | |
| GeneFamily | AT-rich interaction domain containing | 1.81e-03 | 15 | 77 | 2 | 418 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.84e-03 | 57 | 77 | 3 | 1179 | |
| GeneFamily | T-boxes | 2.62e-03 | 18 | 77 | 2 | 766 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.58e-09 | 159 | 106 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.71e-08 | 148 | 106 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-07 | 161 | 106 | 7 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-07 | 171 | 106 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.98e-07 | 133 | 106 | 6 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 146 | 106 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Mild-Lymphoid-NK-CD8_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.80e-06 | 165 | 106 | 6 | 9b0b037383e3e7cf7cfbc65b8d4c4721be3210f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-06 | 167 | 106 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-06 | 175 | 106 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.57e-06 | 186 | 106 | 6 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.30e-06 | 190 | 106 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | wk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.69e-06 | 192 | 106 | 6 | ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 7.74e-06 | 197 | 106 | 6 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | 2591e08e3fbee86ac40f11becd8147d6d39fded6 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.97e-06 | 198 | 106 | 6 | ebc064dede536eda7715af0675fd4e657ff4ac5d | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.20e-06 | 199 | 106 | 6 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 122 | 106 | 5 | a4220adb4e6055a599bd9bbf65d460fc4e68b543 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 128 | 106 | 5 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.07e-05 | 139 | 106 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 150 | 106 | 5 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 150 | 106 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.70e-05 | 157 | 106 | 5 | 62f029831c420d3e9580822177545eb7fdf4d0a3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.93e-05 | 159 | 106 | 5 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-05 | 162 | 106 | 5 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 163 | 106 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.43e-05 | 163 | 106 | 5 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.43e-05 | 163 | 106 | 5 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 5.26e-05 | 169 | 106 | 5 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 171 | 106 | 5 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 171 | 106 | 5 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 171 | 106 | 5 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-05 | 171 | 106 | 5 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-05 | 172 | 106 | 5 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.87e-05 | 173 | 106 | 5 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.87e-05 | 173 | 106 | 5 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 175 | 106 | 5 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 175 | 106 | 5 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.37e-05 | 176 | 106 | 5 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.55e-05 | 177 | 106 | 5 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-05 | 178 | 106 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 181 | 106 | 5 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 7.27e-05 | 181 | 106 | 5 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 181 | 106 | 5 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 181 | 106 | 5 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 182 | 106 | 5 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 182 | 106 | 5 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.66e-05 | 183 | 106 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.86e-05 | 184 | 106 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.86e-05 | 184 | 106 | 5 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.86e-05 | 184 | 106 | 5 | abb61e744a9031e0c91eb560a8f486a0ca5a01cc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 185 | 106 | 5 | 3d6711030ca4328357b06d5497cf98cdefcd7f4f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 185 | 106 | 5 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 185 | 106 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 185 | 106 | 5 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-05 | 185 | 106 | 5 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 185 | 106 | 5 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.06e-05 | 185 | 106 | 5 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 187 | 106 | 5 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 187 | 106 | 5 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 188 | 106 | 5 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-05 | 189 | 106 | 5 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.14e-05 | 190 | 106 | 5 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-05 | 191 | 106 | 5 | 73b15ffa60d592c43aaa575f1b1479d49a66dfe8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.60e-05 | 192 | 106 | 5 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.60e-05 | 192 | 106 | 5 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.84e-05 | 193 | 106 | 5 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.01e-04 | 194 | 106 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.01e-04 | 194 | 106 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-04 | 194 | 106 | 5 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 1.01e-04 | 194 | 106 | 5 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 195 | 106 | 5 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-04 | 195 | 106 | 5 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 195 | 106 | 5 | b5ee368c97113432fc8fe742654cd538558f327c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-04 | 196 | 106 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 196 | 106 | 5 | 7dff78ff7b2b333680de1c9ca78190770574d796 | |
| ToppCell | mild-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.06e-04 | 196 | 106 | 5 | 9c351306b6aae68ed47d4cb1911957bf67f9e1ae | |
| ToppCell | severe_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.08e-04 | 197 | 106 | 5 | cdffd49db7374d223ded46d636cd4be12d464ea4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 197 | 106 | 5 | 15bcfe6105c0b508811fb9bba0bc4312fea04f4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 197 | 106 | 5 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 1.08e-04 | 197 | 106 | 5 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-04 | 198 | 106 | 5 | cf0fda1a24449cfd8ed56ffc7841d8accb187949 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 198 | 106 | 5 | dc59442e6a5127d3071a036c206732a21e456a17 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-04 | 198 | 106 | 5 | 7e1f08dae11a7cc7949a5622d82c7e6660d06dea | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.11e-04 | 198 | 106 | 5 | 525adc91fd8f2ad957b1879a5bf3950baa7d5ef8 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.11e-04 | 198 | 106 | 5 | 70e62d815b2a0aa5327ff94d6f4d503176e007b9 | |
| ToppCell | COVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 1.11e-04 | 198 | 106 | 5 | dfe92577c7d1e63315c7564d5d99362c6e7d4d46 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-04 | 198 | 106 | 5 | 0128d00e6c3f99a026329dd169c0ea5e0e24c59c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-04 | 198 | 106 | 5 | 51c220507bb05aa6338fec494b8ecf4902437708 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 1.11e-04 | 198 | 106 | 5 | b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 1.11e-04 | 198 | 106 | 5 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 106 | 5 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.14e-04 | 199 | 106 | 5 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 199 | 106 | 5 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | COVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class | 1.14e-04 | 199 | 106 | 5 | babbf3220cc811a1794032e06c6cec4dfc7bff2f | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 199 | 106 | 5 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Classical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 1.14e-04 | 199 | 106 | 5 | 93f25e8f22deb438c930c2e95e572dbd16503f71 | |
| Computational | Genes in the cancer module 396. | 3.41e-07 | 12 | 57 | 4 | MODULE_396 | |
| Computational | Neurotransmitter (GABA) receptor. | 9.29e-07 | 15 | 57 | 4 | MODULE_215 | |
| Computational | Genes in the cancer module 141. | 1.23e-06 | 16 | 57 | 4 | MODULE_141 | |
| Computational | Ion channels. | 1.14e-05 | 27 | 57 | 4 | MODULE_214 | |
| Computational | Genes in the cancer module 289. | 4.68e-05 | 124 | 57 | 6 | MODULE_289 | |
| Computational | Ion channels. | 5.02e-04 | 70 | 57 | 4 | MODULE_316 | |
| Drug | tetrazepam | 6.42e-11 | 16 | 105 | 6 | CID000025215 | |
| Drug | dihydroxyaflavinine | 9.89e-11 | 17 | 105 | 6 | CID000156857 | |
| Drug | etizolam | 4.27e-10 | 4 | 105 | 4 | ctd:C044610 | |
| Drug | prazepam | 4.27e-10 | 21 | 105 | 6 | CID000004890 | |
| Drug | imidazenil | 5.85e-10 | 22 | 105 | 6 | CID000119194 | |
| Drug | bretazenil | 7.89e-10 | 23 | 105 | 6 | CID000107926 | |
| Drug | fosazepam | 8.56e-10 | 11 | 105 | 5 | CID000037114 | |
| Drug | C19H18ClN3O | 8.56e-10 | 11 | 105 | 5 | CID000027452 | |
| Drug | flutoprazepam | 8.56e-10 | 11 | 105 | 5 | CID000003400 | |
| Drug | Arfendazam | 8.56e-10 | 11 | 105 | 5 | CID000065803 | |
| Drug | camazepam | 8.56e-10 | 11 | 105 | 5 | CID000037367 | |
| Drug | Bu-1014 | 8.56e-10 | 11 | 105 | 5 | CID015942721 | |
| Drug | Zapizolam | 8.56e-10 | 11 | 105 | 5 | CID000068832 | |
| Drug | Reclazepam | 8.56e-10 | 11 | 105 | 5 | CID003052777 | |
| Drug | iclazepam | 8.56e-10 | 11 | 105 | 5 | CID000068777 | |
| Drug | menitrazepam | 8.56e-10 | 11 | 105 | 5 | CID000189875 | |
| Drug | Serin hydrazid | 8.56e-10 | 11 | 105 | 5 | CID000041637 | |
| Drug | sulazepam | 8.56e-10 | 11 | 105 | 5 | CID000017931 | |
| Drug | elfazepam | 8.56e-10 | 11 | 105 | 5 | CID000065445 | |
| Drug | triflubazam | 8.56e-10 | 11 | 105 | 5 | CID000031157 | |
| Drug | uldazepam | 8.56e-10 | 11 | 105 | 5 | CID000034274 | |
| Drug | gidazepam | 8.56e-10 | 11 | 105 | 5 | CID000121919 | |
| Drug | fletazepam | 8.56e-10 | 11 | 105 | 5 | CID000036834 | |
| Drug | methohexital | 1.05e-09 | 24 | 105 | 6 | CID000009034 | |
| Drug | SB-205384 | 1.46e-09 | 12 | 105 | 5 | CID000197690 | |
| Drug | U-93631 | 1.46e-09 | 12 | 105 | 5 | CID000197626 | |
| Drug | haloxazolam | 1.46e-09 | 12 | 105 | 5 | CID000003563 | |
| Drug | doxefazepam | 1.46e-09 | 12 | 105 | 5 | CID000038668 | |
| Drug | pivoxazepam | 1.46e-09 | 12 | 105 | 5 | CID000068722 | |
| Drug | razobazam | 1.46e-09 | 12 | 105 | 5 | CID000071228 | |
| Drug | nerisopam | 2.37e-09 | 13 | 105 | 5 | CID000065875 | |
| Drug | flutazolam | 2.37e-09 | 13 | 105 | 5 | CID000003398 | |
| Drug | 4-PIOL | 2.37e-09 | 13 | 105 | 5 | CID000125520 | |
| Drug | AC1MVFYM | 2.37e-09 | 13 | 105 | 5 | CID003707225 | |
| Drug | Ro 11-3128 | 2.37e-09 | 13 | 105 | 5 | CID000093364 | |
| Drug | cinolazepam | 2.37e-09 | 13 | 105 | 5 | CID003033621 | |
| Drug | alpha IMGBL | 2.37e-09 | 13 | 105 | 5 | CID000131516 | |
| Drug | metaclazepam | 2.37e-09 | 13 | 105 | 5 | CID000071272 | |
| Drug | Finrazole | 3.55e-09 | 51 | 105 | 7 | CID000178036 | |
| Drug | tofisopam | 3.63e-09 | 29 | 105 | 6 | CID000005502 | |
| Drug | beta-CCt | 3.67e-09 | 14 | 105 | 5 | CID000124514 | |
| Drug | Me-lex | 3.67e-09 | 14 | 105 | 5 | CID000004177 | |
| Drug | ethyl loflazepate | 3.67e-09 | 14 | 105 | 5 | CID000003299 | |
| Drug | 3-isothujone | 4.52e-09 | 30 | 105 | 6 | CID000011027 | |
| Drug | SR 95103 | 5.49e-09 | 15 | 105 | 5 | CID000125958 | |
| Drug | pinazepam | 5.49e-09 | 15 | 105 | 5 | CID000040391 | |
| Drug | fludiazepam | 5.49e-09 | 15 | 105 | 5 | CID000003369 | |
| Drug | TBOB | 5.49e-09 | 15 | 105 | 5 | CID000114986 | |
| Drug | loprazolam | 5.49e-09 | 15 | 105 | 5 | CID003033860 | |
| Drug | premazepam | 5.49e-09 | 15 | 105 | 5 | CID000072104 | |
| Drug | girisopam | 5.49e-09 | 15 | 105 | 5 | CID000071257 | |
| Drug | Meprobamate | 6.36e-09 | 6 | 105 | 4 | DB00371 | |
| Drug | Flunitrazepam | 6.36e-09 | 6 | 105 | 4 | DB01544 | |
| Drug | P858 | 7.95e-09 | 16 | 105 | 5 | CID000004617 | |
| Drug | nimetazepam | 7.95e-09 | 16 | 105 | 5 | CID000004496 | |
| Drug | Ro 19-4603 | 7.95e-09 | 16 | 105 | 5 | CID000127382 | |
| Drug | CGS 8216 | 8.34e-09 | 33 | 105 | 6 | CID000104916 | |
| Drug | AC1L2FYN | 8.34e-09 | 33 | 105 | 6 | CID000071333 | |
| Drug | temazepam | 1.01e-08 | 34 | 105 | 6 | CID000005391 | |
| Drug | CL 218,872 | 1.12e-08 | 17 | 105 | 5 | CID000107950 | |
| Drug | flurazepam | 1.21e-08 | 35 | 105 | 6 | CID000003393 | |
| Drug | FG 7142 | 1.45e-08 | 36 | 105 | 6 | CID000004375 | |
| Drug | abecarnil | 1.55e-08 | 18 | 105 | 5 | CID000065914 | |
| Drug | cloxazolam | 1.55e-08 | 18 | 105 | 5 | CID000002816 | |
| Drug | clorazepate | 1.55e-08 | 18 | 105 | 5 | CID000002809 | |
| Drug | lormetazepam | 1.55e-08 | 18 | 105 | 5 | CID000013314 | |
| Drug | phenazepam | 1.55e-08 | 18 | 105 | 5 | CID000040113 | |
| Drug | secobarbital | 1.72e-08 | 37 | 105 | 6 | CID000005193 | |
| Drug | DMCM | 2.04e-08 | 38 | 105 | 6 | CID000104999 | |
| Drug | etifoxine | 2.09e-08 | 19 | 105 | 5 | CID000030768 | |
| Drug | ZK 93426 | 2.09e-08 | 19 | 105 | 5 | CID000115210 | |
| Drug | zaleplon | 2.40e-08 | 39 | 105 | 6 | CID000005719 | |
| Drug | halazepam | 2.78e-08 | 20 | 105 | 5 | CID000031640 | |
| Drug | AC1N65YL | 2.78e-08 | 20 | 105 | 5 | CID004229818 | |
| Drug | Ro 15-4513 | 2.78e-08 | 20 | 105 | 5 | CID000005081 | |
| Drug | EBOB | 2.78e-08 | 20 | 105 | 5 | CID000115223 | |
| Drug | Gabrene | 2.81e-08 | 40 | 105 | 6 | CID005361323 | |
| Drug | gaboxadol | 3.28e-08 | 41 | 105 | 6 | CID000003448 | |
| Drug | bicuculline methochloride | 3.64e-08 | 21 | 105 | 5 | CID000123659 | |
| Drug | R 5135 | 3.64e-08 | 21 | 105 | 5 | CID000119544 | |
| Drug | PK11195 | 3.82e-08 | 42 | 105 | 6 | CID000001345 | |
| Drug | 5 beta-alphaxalone | 3.82e-08 | 42 | 105 | 6 | CID000068930 | |
| Drug | zolpidem | 4.42e-08 | 43 | 105 | 6 | CID000005732 | |
| Drug | Iomazenil (123I | 4.69e-08 | 22 | 105 | 5 | CID000065959 | |
| Drug | quazepam | 4.69e-08 | 22 | 105 | 5 | CID000004999 | |
| Drug | etizolam | 4.69e-08 | 22 | 105 | 5 | CID000003307 | |
| Drug | 6 mEq | 4.69e-08 | 22 | 105 | 5 | CID000126186 | |
| Drug | lorazepam | 5.10e-08 | 44 | 105 | 6 | CID000003958 | |
| Drug | Ethchlorvynol | 5.29e-08 | 9 | 105 | 4 | DB00189 | |
| Drug | chlordiazepoxide | 5.74e-08 | 114 | 105 | 8 | CID000002712 | |
| Drug | adinazolam | 5.97e-08 | 23 | 105 | 5 | CID000037632 | |
| Drug | zolazepam | 5.97e-08 | 23 | 105 | 5 | CID000035775 | |
| Drug | thymol | 6.72e-08 | 46 | 105 | 6 | CID000006989 | |
| Drug | heptachlor epoxide | 6.72e-08 | 46 | 105 | 6 | CID000013930 | |
| Drug | gamma-acetylenic GABA | 7.51e-08 | 24 | 105 | 5 | CID000003452 | |
| Drug | medazepam | 7.51e-08 | 24 | 105 | 5 | CID000004041 | |
| Drug | alpidem | 7.51e-08 | 24 | 105 | 5 | CID000054897 | |
| Drug | SL 75102 | 7.51e-08 | 24 | 105 | 5 | CID005751746 | |
| Drug | beta-CCM | 7.51e-08 | 24 | 105 | 5 | CID000107704 | |
| Drug | nitrazepam | 7.67e-08 | 47 | 105 | 6 | CID000004506 | |
| Disease | amino acid measurement | EPHB2 GABRG3 WWP2 GRB10 NDST3 TBX18 SPOCK3 CSMD1 MTUS2 PLXNA2 GABRA2 | 2.80e-05 | 678 | 104 | 11 | EFO_0005134 |
| Disease | Isodicentric Chromosome 15 Syndrome | 3.68e-05 | 3 | 104 | 2 | C3711376 | |
| Disease | Osteochondrodysplasias | 3.96e-05 | 19 | 104 | 3 | C0029422 | |
| Disease | Schizophrenia | GABRG2 RELN RANBP9 GRB10 UGT1A3 NDST3 TET1 CSMD1 PHOX2B PLXNA2 GABRA5 GABRA6 | 6.64e-05 | 883 | 104 | 12 | C0036341 |
| Disease | Geleophysic dysplasia | 1.22e-04 | 5 | 104 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.22e-04 | 5 | 104 | 2 | C0265287 | |
| Disease | diastolic blood pressure, systolic blood pressure | FNDC3B FLT1 RANBP9 GRB10 TBX18 LRIG3 ARID5B DLEC1 TAF2 GABRA6 | 1.31e-04 | 670 | 104 | 10 | EFO_0006335, EFO_0006336 |
| Disease | leiomyosarcoma (is_marker_for) | 1.83e-04 | 6 | 104 | 2 | DOID:1967 (is_marker_for) | |
| Disease | age of onset of Alzheimer disease | 2.15e-04 | 33 | 104 | 3 | OBA_2001000 | |
| Disease | Dystonia | 2.48e-04 | 86 | 104 | 4 | C0013421 | |
| Disease | Seizure, Febrile, Simple | 2.55e-04 | 7 | 104 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 2.55e-04 | 7 | 104 | 2 | C0751057 | |
| Disease | annexin A2 measurement | 2.55e-04 | 7 | 104 | 2 | EFO_0008027 | |
| Disease | X-11793--oxidized bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021260 | |
| Disease | Succinimide measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0022118 | |
| Disease | X-11530 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800696 | |
| Disease | X-10458 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800692 | |
| Disease | X-24849 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0802740 | |
| Disease | X-16946 measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0800766 | |
| Disease | Alcoholic Intoxication, Chronic | 3.83e-04 | 268 | 104 | 6 | C0001973 | |
| Disease | X-11442 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0800698 | |
| Disease | Febrile Convulsions | 4.36e-04 | 9 | 104 | 2 | C0009952 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.36e-04 | 9 | 104 | 2 | EFO_0004570, GO_0009410 | |
| Disease | hypothyroidism | 5.20e-04 | 284 | 104 | 6 | EFO_0004705 | |
| Disease | lactose measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0010507 | |
| Disease | bilirubin measurement, response to tenofovir | 5.44e-04 | 10 | 104 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.44e-04 | 10 | 104 | 2 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0010219 | |
| Disease | eosinophil count | ICE2 WWP2 MKRN2 MR1 GRB10 PLPPR3 ACAD10 MPIG6B TERT ARID5A ITK MDN1 LTBP3 ZC3H7B | 7.33e-04 | 1488 | 104 | 14 | EFO_0004842 |
| Disease | p-cresol glucuronide measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0800079 | |
| Disease | stenosing tenosynovitis | 7.94e-04 | 12 | 104 | 2 | EFO_0010822 | |
| Disease | biliverdin measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0021033 | |
| Disease | triacylglycerol 44:1 measurement | 7.94e-04 | 12 | 104 | 2 | EFO_0010399 | |
| Disease | autistic disorder (is_marker_for) | 7.94e-04 | 12 | 104 | 2 | DOID:12849 (is_marker_for) | |
| Disease | serum selenium measurement | 8.77e-04 | 53 | 104 | 3 | EFO_0005266 | |
| Disease | retinol dehydrogenase 16 measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0802007 | |
| Disease | serum alanine aminotransferase measurement | FNDC3B FLT1 WWP2 NDST4 SERINC2 ITK NYNRIN TET1 HSD17B13 PISD | 1.00e-03 | 869 | 104 | 10 | EFO_0004735 |
| Disease | Intellectual Disability | 1.05e-03 | 447 | 104 | 7 | C3714756 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.11e-03 | 128 | 104 | 4 | DOID:4450 (is_marker_for) | |
| Disease | anxiety | 1.18e-03 | 223 | 104 | 5 | EFO_0005230 | |
| Disease | pulse pressure measurement | FNDC3B DSCAM WWP2 CD46 ACAD10 ARID5A TBX18 LRIG3 ADRA2B TET1 DLEC1 LTBP3 GABRA6 | 1.22e-03 | 1392 | 104 | 13 | EFO_0005763 |
| Disease | Spondyloepiphyseal Dysplasia | 1.43e-03 | 16 | 104 | 2 | C0038015 | |
| Disease | response to triptolide, cytotoxicity measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.43e-03 | 16 | 104 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.43e-03 | 16 | 104 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.43e-03 | 16 | 104 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.43e-03 | 16 | 104 | 2 | C0025237 | |
| Disease | gestational age | 1.47e-03 | 138 | 104 | 4 | EFO_0005112 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.62e-03 | 17 | 104 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Van Buchem disease | 1.62e-03 | 17 | 104 | 2 | C0432272 | |
| Disease | Microcephaly | 1.73e-03 | 67 | 104 | 3 | C0025958 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.81e-03 | 68 | 104 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | glucuronate measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0010486 | |
| Disease | angiopoietin-related protein 1 measurement | 1.81e-03 | 18 | 104 | 2 | EFO_0801382 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.81e-03 | 18 | 104 | 2 | HP_0002373 | |
| Disease | aortic measurement | 1.99e-03 | 251 | 104 | 5 | EFO_0020865 | |
| Disease | obsessive-compulsive disorder, autism spectrum disorder | 2.02e-03 | 19 | 104 | 2 | EFO_0003756, EFO_0004242 | |
| Disease | Dyschondroplasias | 2.02e-03 | 19 | 104 | 2 | C0013366 | |
| Disease | intraocular pressure measurement | 2.20e-03 | 509 | 104 | 7 | EFO_0004695 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.24e-03 | 20 | 104 | 2 | C0026760 | |
| Disease | Autistic Disorder | 2.35e-03 | 261 | 104 | 5 | C0004352 | |
| Disease | tissue factor measurement | 2.47e-03 | 21 | 104 | 2 | EFO_0010623 | |
| Disease | Lung diseases | 2.67e-03 | 78 | 104 | 3 | C0024115 | |
| Disease | Seckel syndrome | 2.71e-03 | 22 | 104 | 2 | C0265202 | |
| Disease | Primary microcephaly | 2.71e-03 | 22 | 104 | 2 | C0431350 | |
| Disease | Hodgkin Disease | 2.71e-03 | 22 | 104 | 2 | C0019829 | |
| Disease | creatinine measurement | DSCAM ICE2 EPB41L5 GRB10 SERINC2 ACAD10 SLC35F3 ARID5B DLEC1 CTSB | 2.72e-03 | 995 | 104 | 10 | EFO_0004518 |
| Disease | Disease Exacerbation | 2.81e-03 | 165 | 104 | 4 | C0235874 | |
| Disease | sensory peripheral neuropathy, remission | 2.97e-03 | 23 | 104 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | QRS duration, response to sulfonylurea | 2.97e-03 | 23 | 104 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | COVID-19, mortality | 3.13e-03 | 170 | 104 | 4 | EFO_0004352, MONDO_0100096 | |
| Disease | response to antiviral drug, cirrhosis of liver | 3.23e-03 | 24 | 104 | 2 | EFO_0001422, EFO_0010123 | |
| Disease | autoimmune disease | 3.33e-03 | 173 | 104 | 4 | EFO_0005140 | |
| Disease | Autism Spectrum Disorders | 3.41e-03 | 85 | 104 | 3 | C1510586 | |
| Disease | nicotine dependence symptom count | 3.43e-03 | 285 | 104 | 5 | EFO_0009262 | |
| Disease | pre-eclampsia (is_implicated_in) | 3.50e-03 | 25 | 104 | 2 | DOID:10591 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPLALSYICHAFSAP | 216 | P35503 | |
| GKFLPCSSYIDSYDP | 16 | Q9H2A2 | |
| AAPIFKGCFYTHPTE | 336 | Q03989 | |
| GYSPPSKCEQTDLYH | 131 | O94986 | |
| CEPGYSPTYKQDKHY | 211 | P07858 | |
| FVKYQCHPGYTLVGT | 2281 | Q96PZ7 | |
| LPTFGYTLVYTCHPG | 3291 | Q96PZ7 | |
| YTLVYTCHPGFFLAG | 3296 | Q96PZ7 | |
| KYLHTTIFGLTSYCP | 266 | Q9BX10 | |
| VAYSCLAHYLPSSFP | 496 | Q6JQN1 | |
| PFFFSYSLGAICPKH | 386 | P18089 | |
| ASTCTLKPGIVYYHG | 106 | Q5VUY0 | |
| KGGHTSVVCYLLDYP | 706 | O75179 | |
| YFPPKVLCGVDYSHD | 181 | P21730 | |
| HEGIPYLIPYCSSKF | 176 | Q7Z5P4 | |
| YTSLPDFCHKFLPGY | 111 | Q9UBM7 | |
| YIAAFPPHEGAYKSS | 336 | Q9BYT9 | |
| TCPFGSKCLYRHAYP | 336 | Q9H000 | |
| GKEEFCSPPYAHYEV | 741 | Q5JR59 | |
| TCGLFTHTIFYKEYP | 476 | O95803 | |
| HPIPAACGIYYFEVK | 206 | Q96S59 | |
| GPTFPTYYAHADTLC | 3446 | Q9NU22 | |
| CGYPPFYSKHHSRTI | 236 | Q8IW41 | |
| KGYFYIPPLATHTIC | 66 | P15529 | |
| KTYSCHCQPPFSGKY | 196 | Q5T1H1 | |
| FYSYDIPHTCGPDPK | 351 | Q16706 | |
| YGSDPFETYHTGCSP | 936 | Q6UXM1 | |
| FYSALPGYICSHSPV | 401 | P51654 | |
| FSDPIRHKFPFCYST | 321 | P60608 | |
| ACFLPDSSLPDYHYI | 196 | Q86WG3 | |
| DAHSCPLKFGSYAYT | 176 | P47869 | |
| PSVPGSCKETFNLYY | 101 | P29323 | |
| DDPKFHSYVSLPFGC | 286 | O75051 | |
| LDCPDGSTIPYQYKH | 8351 | Q7Z5P9 | |
| GGYYPEPSKLCHLDQ | 466 | Q9Y4A8 | |
| YPDDYVHISSKPCDL | 136 | Q86TH1 | |
| DVHACPLKFGSYAYT | 201 | P34903 | |
| ACPLKFGSYAYPNSE | 186 | P31644 | |
| DGHACPLKFGSYAYP | 166 | Q16445 | |
| PLYRHAAPYSYDCTK | 486 | Q99958 | |
| HPSECCFTYTTYKIP | 31 | Q16627 | |
| CGLFTHTIFYKEYPG | 476 | Q9H3R1 | |
| VSTPKPGYFGLFHYC | 51 | Q7Z7J7 | |
| GKETRCSPPSFTYKY | 761 | P28290 | |
| EPPSSSHYCLYSYRG | 31 | Q9HAS0 | |
| PPVVSCYNASDHVYK | 156 | O95274 | |
| GYSGPNCYLTHTLKT | 2876 | P78509 | |
| GDYSAYGVPLKPLCH | 236 | Q99853 | |
| YLAEKFTPSSPCGLY | 156 | Q1HG44 | |
| GSPYCLHLRVKFYSS | 111 | Q9HCM4 | |
| YNLYKTHCGLPGVPS | 886 | Q659A1 | |
| SFYSHGLPRCSPYKK | 481 | P55265 | |
| PYGKEISYTCDPHPD | 1341 | P17927 | |
| DEHSCPLIFSSYGYP | 181 | Q99928 | |
| PHSGLSFPYSYEVAL | 306 | Q53EP0 | |
| EHSCPLEFSSYGYPR | 201 | P18507 | |
| PCSPKDFAHVFTEYG | 191 | Q9NY37 | |
| IYPCPVYSSAEFHSL | 956 | Q9NS15 | |
| FYSYDVPHTCGPDPK | 351 | P49641 | |
| NGPYPYTLKLCFSTA | 571 | P14866 | |
| CPDSFLHHPYYQDKV | 6 | Q13322 | |
| HRLDTEAPYCGPSSY | 521 | Q5T749 | |
| DYRKGHFECPPYNSS | 131 | Q9UK59 | |
| YPSTKVYFPHLSACQ | 36 | Q6B0K9 | |
| FKSHSLYPPCYVHDV | 526 | Q9BRP7 | |
| DYYTDTVPFHSAPKG | 211 | Q9Y238 | |
| YHAFSSLCYFTPILG | 86 | Q16348 | |
| KYIHCSSPDTTEPGY | 111 | Q92613 | |
| CLYYKPPGWSEHSDF | 101 | Q6ISS4 | |
| LSFSCSPYTPTYAHL | 1341 | Q9P2P1 | |
| TKNFAEEPIYCYTPH | 71 | Q96RD6 | |
| AYGSPCYALFLSPKS | 46 | Q6UW15 | |
| FCKAHGFYPPEIYMT | 221 | Q95460 | |
| TSEHCYQKPRAYYPA | 836 | Q9BVI0 | |
| VKSDISIPCHYKYPF | 66 | Q08881 | |
| KYTVFCSHPYPTVIS | 1221 | O60469 | |
| TYGLPCHCPFKEGTY | 131 | P17900 | |
| KGPPFYHASYSVIIE | 371 | Q8NCE0 | |
| PAGSTLIFYKYCDHE | 371 | Q8NFQ8 | |
| HVPSDPALFKSYAEY | 866 | Q6P1X5 | |
| RTYCKAPGPTHGSVY | 126 | O95866 | |
| GVFYDLDSCKHSSYP | 21 | Q01892 | |
| ASCQYYFEKIHPPGE | 121 | Q8IXM7 | |
| EKHYTLCGTPNYISP | 166 | O00444 | |
| FFPLYYVGHVCKSTE | 111 | Q8IY50 | |
| YLDPIKSEHDCYPTS | 286 | Q8NFU7 | |
| SPCGLHGPYIFYKAF | 11 | Q14865 | |
| KKSAYCPYSHFPVGA | 26 | P32320 | |
| SCSPHENILPYKYTS | 276 | Q7Z7G1 | |
| YSHLVSVGYCIPKPE | 41 | P17032 | |
| PTAYCYTFTDPHIIT | 421 | Q8N2E2 | |
| HTCFNRLDLPPYKSY | 836 | O00308 | |
| YGEKPYTHTQCGTAF | 136 | Q8N8Z8 | |
| GYHTPFFLTVCKPNY | 156 | Q6T4P5 | |
| PCALYGYNFSTSPKL | 526 | O95935 | |
| PEALSCSFHPSYDFY | 461 | Q9Y458 | |
| IYLAPGDYHCFHSPT | 256 | Q9UG56 | |
| APVELKCNYSYSGSP | 36 | A0A0A6YYK6 | |
| KGHLFYPYPSCTETA | 476 | Q8TDW4 | |
| DPLPCTTDSYGYHSY | 731 | Q5HYM0 | |
| YPSPVCGSDGHTYSF | 146 | Q9BQ16 | |
| YSHLVSVGYCFTKPE | 41 | Q6ZMW2 | |
| HTGFYSCKYLAVPTS | 101 | P17948 | |
| SPYAAVPYKLFTDHG | 76 | Q99453 | |
| YYTEPSGCHEGKVFI | 226 | Q96SA4 | |
| LPTAFLPSKYHGYEE | 606 | Q6P2D8 | |
| CPPVYAETKHFLYSS | 321 | O14746 | |
| PRPTKTSFVGSYYLC | 471 | Q9UGR2 | |
| YPLALSYICHTFSAP | 216 | P22310 | |
| GPCDKTSHPYQAALY | 26 | Q92876 |